United Therapeutics Receives Subpoena from Office of Inspector General

United Therapeutics (NASDAQ: UTHR ) announced today that it has received a subpoena from the Office of the Inspector General of the Department of Health and Human Services reflecting an investigation by the United States Department of Justice, principally represented by the United States Attorney's Office in Baltimore. The